Cumberland Pharmaceuticals (CPIX) Reports Q3 Loss of $0.07/sh

Cumberland Pharmaceuticals (NASDAQ: CPIX) reported Q3 EPS of ($0.07), versus ($0.03) reported last year. Revenue for the quarter came in at $8.1 million, versus $9.25 million reported last year.

For earnings history and earnings-related data on Cumberland Pharmaceuticals (CPIX) click here.

You May Also Be Interested In

• Tesla to launch Cybercab in Austin this month - report
• BofA sees Micron EPS topping $230 by FY30, calls peak fears overblown
• Flexsteel (FLXS) Tops Q4 EPS by 24c, Beats on Revenue; Offers Q1 Revenue Guidance